Browse drugs

…Introduction The long-acting injectable dual therapy cabotegravir + rilpivirine improves quality of life and adherence in virolog…

…t (IQ) over time during follow-up from month 1 to month 31. (a) Rilpivirine IQ, (b) CAB IQ; Linear red solid line represents the IQ cut-off…

…Background The widespread adoption of cabotegravir (CAB)/rilpivirine (RPV) long-acting (LA) in clinical practice m…

…bolic changes in people with HIV (PWH) switching to long-acting cabotegravir + rilpivirine (LA CAB+RPV) are still limited. The objective of …

…Background Long-acting injectable antiretroviral therapy with cabotegravir plus rilpivirine (CAB/RPV LA) represents a paradigm shift in th…

…Background The long-acting (LA) treatment with cabotegravir (CAB) and rilpivirine (RPV) has been reported to have a neutral…

… against other sexually transmitted infections. Currently, only Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) is reimbursed by the NHS in Spain. PrEP is indicated …

…ion strategy. The recent introduction of long-acting injectable cabotegravir (LA-PrEP) has expanded the available options beyond oral therap…

…. Unlike regimens containing tenofovir with lamivudine (3TC) or emtricitabine (FTC), it lacks therapeutic activity against the hepatitis B vi…

…evel resistance to emtricitabine and intermediate resistance to rilpivirine. To attenuate further resistance, 4-weekly dosing of LAI-ART wa…

…ng from the recommended use and dosing schedule. These included doxycycline (200 mg two times per day daily for three consecutive days), az…